NCT02084654View on ClinicalTrials.gov

Exenatide and Weight Loss for Diabetes Prevention

PHASE1CompletedINTERVENTIONAL
Enrollment

66

Participants

Timeline

Start Date

November 30, 2007

Primary Completion Date

October 31, 2012

Study Completion Date

February 28, 2013

Conditions
Pre DiabetesInsulin Resistance
Interventions
DRUG

Exenatide 5 and 10 mcg 2 times a day

DRUG

placebo

All Listed Sponsors
lead

Stanford University

OTHER

NCT02084654 - Exenatide and Weight Loss for Diabetes Prevention | Biotech Hunter | Biotech Hunter